Intrinsic Value of S&P & Nasdaq Contact Us

Ocean Biomedical, Inc. OCEA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ocean Biomedical, Inc. (OCEA) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
34/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — OCEA

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.12
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.01 $0.00 $-232K -
2020 $-0.08 $0.00 $-1.65M -
2021 $-4.71 $0.00 $-62.34M -
2022 $0.03 $0.00 $565.47K -
2024 $-0.12 $0.00 $-3.3M -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message